Skip to main content

BRCA 2

Image placeholder title
Breast Cancer Treatment

PARP Inhibitors improve outcomes in BRCA mutated breast cancer. FDA approves Lynparza for treatment of TNBC and early stage breast cancer.

By Dr. C.H. Weaver M.D.Apr 30, 2022
Image placeholder title
Ovarian Cancer Treatment

Lynparza Delays Progression & Significantly Prolongs Survival in Ovarian Cancer

By Dr. C.H. Weaver M.D.Nov 19, 2021
Image placeholder title
Breast Cancer Overviews

Precision Cancer Medicines and Breast Cancer

By Dr. C.H. Weaver M.D.Feb 9, 2022
CancerConnect CC Green Background 1620x700
Breast Cancer Survivorship

Hereditary Breast and Ovarian Cancer: What you need to know about risk

By Dr. C.H. Weaver M.D.Oct 9, 2021
shutterstock_1226264584
Breast Cancer Overviews

Male BRCA2 Carriers Have Increased Lifetime Risk of Breast Cancer

By CancerConnectMay 26, 2022
CHEK2 Gene Mutations Increase Breast Cancer Risk
Breast Cancer

CHEK2 Gene Mutations Increase Breast Cancer Risk

By CancerConnectOct 13, 2021